Kanarb sales at brisk pace

Published: 2011-06-08 06:56:00
Updated: 2011-06-08 06:56:00
Boryung Pharmaceutical, one of Korea’s leading drug makers, is enjoying brisk sales of its new antihypertensive drug, Kanarb.

Sales of Dong-A’s antihypertensive agent recorded over 1.3 billion won since its release in March 2011.

If Kanarb is successfully landed in general hospitals, its s...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.